AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19770473
Drug: Telcagepant 150
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant 150 mg
Trial: 21813569
Drug: Transfer into
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transfer into an open cot at 1800 g
Trial: 16766975
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (VAC) for fractures
Trial: 18094221
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg rifampin
Trial: 23904465
Drug: BPA exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BPA exposure (20, 200 ng/ml or 20 µg/ml)
Trial: 22278344
Drug: 126 mg
RxNorm normalized name: glycerin 126 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 126 mg soy germ isoflavones
Trial: 8316616
Drug: Triphasic oral
RxNorm normalized name: CeeNU, triphasic oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic oral contraceptive (OC)
Trial: 3378514
Drug: Atenolol 50mg
RxNorm normalized name: ATENOLOL 50MG TAB
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol 50mg twice daily with sustained release nifedipine 40mg twice daily
Trial: 27628038
Drug: Qing-Xin-Jie-Yu Granules
RxNorm normalized name: Bai jie seed
DrugBank: White mustard seed (DB15606)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qing-Xin-Jie-Yu Granules (QXJYG), twice daily for 6 months
Trial: 19043609
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (inhalation and intravenous antibiotics)
Trial: 9272406
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Valsartan + Furosemide)
Trial: 29443538
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (12-session supervised clinic program)
Trial: 7514046
Drug: Erythropoietin (Epo)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (Epo) and G-CSF
Trial: 26920590
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DES) - sirolimus-eluting stents (SES) and everolimus-eluting stents (EES)
Trial: 28095573
Drug: Vehicle twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle twice daily
Trial: 25240075
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (TPN)
Trial: 22517217
Drug: Amlodipine (AM)
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine (AM) 5 mg
Trial: 12151999
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg efavirenz
Trial: 7740377
Drug: 4-drug regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 4-drug regimen (isoniazid, rifampicin, pyrazinamide, ethambutol)
Trial: 14504812
Drug: Itraconazole solution
RxNorm normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Itraconazole solution
Trial: 14504812
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B solution
Trial: 24603562
Drug: Early supplementing
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early supplementing enteral Microlipid (ML) and fish oil (FO)
Trial: 3291901
Drug: Split-course treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-course treatment (227 patients)
Trial: 28129746
Drug: Graded Exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded Exercise Therapy (GET)
Trial: 18414712
Drug: Oral cannabinoid-containing
RxNorm normalized name: Cannabinol
DrugBank: Cannabinol (DB14737)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cannabinoid-containing medications (OCs)
Trial: 22266603
Drug: 48-week pegylated
RxNorm normalized name: Pegylated rfviii
DrugBank: PEGylated Recombinant Factor VIII (DB16093)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48-week pegylated interferon (PEG-IFN) alfa-2a 180 mcg/week and ribavirin (RBV) 15mg/kg/day
Trial: 7956700
Drug: Tumor infiltrating
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumor infiltrating lymphocytes (TILs) immunotherapy
Trial: 17540797
Drug: Quick Start
RxNorm normalized name: Cal-Quick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quick Start (immediate, directly observed ingestion of the first pill during the clinic visit)
Trial: 15467969
Drug: Antidepressive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressive treatment for 35 days
Trial: 31053896
Drug: N2O inhalation
RxNorm normalized name: N2O
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N2O inhalation sedation or general anesthesia
Trial: 14623834
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sodium diclofenac
Trial: 29582237
Drug: Dabigatran 110
RxNorm normalized name: dabigatran 110 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 110 mg BID (D110)
Trial: 29582237
Drug: Dabigatran 150
RxNorm normalized name: dabigatran 150 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 150 mg BID (D150)
Trial: 28484877
Drug: Celecoxib with
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib with morphine sulfate 10 mg/12 h
Trial: 15011890
Drug: Eradication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eradication therapy (omeprazole, amoxicillin, and clarithromycin)
Trial: 2223363
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at 300 ml h‐1
Trial: 2223363
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at 1200 ml h‐1
Trial: 23895801
Drug: Low-dose methotrexate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methotrexate (target dose 15-20 mg/wk)
Trial: 7611158
Drug: Nicotinic acid
RxNorm normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinic acid and lovastatin combination
Trial: 2775618
Drug: Aminoglycoside dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminoglycoside dosage based on pharmacokinetic analysis
Trial: 9010943
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patch (0.16 mg/cm2) applied 60 minutes before anesthesia induction.
Trial: 3549804
Drug: 2% minoxidil
RxNorm normalized name: MINOXIDIL 2 g in 100 mL TOPICAL LIQUID [2% Minoxidil hair growth serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minoxidil solution
Trial: 23792179
Drug: Antidepressant Medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant Medication (ADM) - unspecified dosage and duration
Trial: 11361050
Drug: Hydrocortisone acetate
RxNorm normalized name: Hydrocortisone Acetate
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone acetate foam (100 mg)
Trial: 22776014
Drug: Teneligliptin 10
RxNorm normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Teneligliptin 10 mg
Trial: 30362280
Drug: Teneligliptin 20
RxNorm normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Teneligliptin 20 mg
Trial: 12854936
Drug: Writing therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Writing therapy intervention
Trial: 14764783
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant human growth hormone (rhGH)
Trial: 19138370
Drug: Topical alprostadil
RxNorm normalized name: Alprostadil
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical alprostadil cream (200 mcg initially, then adjusted)
Trial: 24429155
Drug: Nebulised magnesium
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised magnesium sulphate (MgSO4) 2.5 mL (250 mmol/L; 151 mg per dose)
Trial: 31288822
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with placebo (0.9% sodium chloride solution)
Trial: 12789991
Drug: Colgate Simply
RxNorm normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colgate Simply White Clear Whitening Gel (18% carbamide peroxide)
Trial: 12445410
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg/day
Trial: 22301107
Drug: Drug-releasing implants
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-releasing implants
Trial: 6768078
Drug: Heroin self-administration
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin self-administration with buprenorphine placebo
Trial: 7452507
Drug: Heroin self-administration
RxNorm normalized name: heroin
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin self-administration
Trial: 17452486
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of rifampin (600 mg)
Trial: 19667111
Drug: Adiponectin neutralizing
RxNorm normalized name: DentiCare Neutral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adiponectin neutralizing antibody
Trial: 17454036
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release (CR) tablets of naproxen sodium
Trial: 17454036
Drug: Marketed immediate
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marketed immediate release tablets of naproxen sodium
Trial: 31896686
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment (validation set)
Trial: 26994634
Drug: Opioid pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid pain medications
Trial: 17209507
Drug: Ramipril 15
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril 15 mg/day
Trial: 25914349
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (10, 20, 40 injections)
Trial: 1928881
Drug: Codeine/acetaminophen
RxNorm normalized name: PE/codeine/acetaminophen/cpm ORAL ELIXIR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/acetaminophen
Trial: 3141537
Drug: N-hydroxy-arachidonamide (AH)
RxNorm normalized name: N-ethyl-3-hydroxy-N,N-dimethylanilinium
DrugBank: Edrophonium (DB01010)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-hydroxy-arachidonamide (AH) (topical)
Trial: 3141537
Drug: Phenidone (topical)
RxNorm normalized name: phenindione
DrugBank: Phenindione (DB00498)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenidone (topical)
Trial: 9773735
Drug: Premeal human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premeal human regular insulin before lunch and supper at unchanged dose
Trial: 9773735
Drug: Premeal lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Premeal lispro (unchanged dose) at lunchtime and dinner
Trial: 7027714
Drug: Iv glipizide
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iv glipizide followed 60 min later by oral glucose
Trial: 2322970
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml saline injected prior to catheter insertion
Trial: 19797937
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg controlled-release tramadol
Trial: 26481177
Drug: Cochlear implant
RxNorm normalized name: Cochlearia officinalis leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochlear implant programming for 12 weeks postoperatively or after tinnitus occurrence
Trial: 9446004
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid (Nevigramon) 1 tablet 3 times daily for 21.6 months
Trial: 20386017
Drug: Sotrastaurin 400
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 400 mg
Trial: 20386017
Drug: Sotrastaurin 400
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 400 mg + Tacrolimus 7 mg
Trial: 22455403
Drug: Group psychotherapy
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group psychotherapy (GPT) plus 50 mg sildenafil on-demand
Trial: 25196890
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg/day
Trial: 2995463
Drug: Triple antibiotic
RxNorm normalized name: Triple Antibiotic
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triple antibiotic ointment (bacitracin, polysporin, neomycin) applied thrice daily
Trial: 11408983
Drug: Triple antibiotic
RxNorm normalized name: Triple Antibiotic
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triple antibiotic ointment
Trial: 21328517
Drug: Balaglitazone 10
RxNorm normalized name: Balaglitazone
DrugBank: Balaglitazone (DB12781)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balaglitazone 10 mg
Trial: 9866432
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of beta-blockers to prevent postoperative cardiac complications
Trial: 8793448
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2 mg nedocromil sodium and 100 micrograms salbutamol
Trial: 23340449
Drug: DFMO+sulindac treatment
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DFMO+sulindac treatment in dietary polyamine quartiles 1-3
Trial: 18600434
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g PEG 400 (control)
Trial: 10720272
Drug: Embryonic porcine
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Embryonic porcine VM tissue treated with a monoclonal antibody directed against major histocompatibility complex class I
Trial: 25573027
Drug: Sham electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham electrical stimulation (SES) and conventional swallowing therapy
Trial: 24516695
Drug: Flumazenil injection
RxNorm normalized name: Flumazenil Injection
DrugBank: Flumazenil (DB01205)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flumazenil injection immediately after endoscopy
Trial: 22464118
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy
Trial: 18067816
Drug: Ulinastatin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ulinastatin infusion (6000 U/kg for 30 min, then 1000 U.kg(‐1).h(‐1) until end of operation)
Trial: 3305794
Drug: Matched allogenic
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched allogenic bone marrow transplantation (BMT) following preparation with cyclophosphamide and fractionated total body irradiation (TBI)
Trial: 29183074
Drug: FMT by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FMT by oral capsule
Trial: 140084
Drug: 1% hydrocortisone
RxNorm normalized name: HYDROCORTISONE 0.01 g in 1 g TOPICAL OINTMENT [AFASSCO 1% Hydrocortisone]
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1% hydrocortisone cream
Trial: 6089305
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg cimetidine three times daily and 400 mg at night
Trial: 12171817
Drug: Oxygen inhalation
RxNorm normalized name: oxygen INHALATION GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen inhalation at 2 L/min
Trial: 25058216
Drug: Hemoglobin transfusion
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemoglobin transfusion threshold of 7 g/dL
Trial: 12766103
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine administered before breakfast
Trial: 27111084
Drug: Rivastigmine patch
RxNorm normalized name: Rivastigmine
DrugBank: Rivastigmine (DB00989)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Rivastigmine patch monotherapy
Trial: 30881102
Drug: Morphine 4
RxNorm normalized name: morphine 4 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 4 mg
Trial: 24867603
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (HD, 6 mg.kg(‐1))
Trial: 16946696
Drug: Lamotrigine monotherapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine monotherapy (100-200 mg/day)
Trial: 16946696
Drug: Lamotrigine monotherapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine monotherapy with ASH as supplemental medication
Trial: 16946696
Drug: Lamotrigine monotherapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine monotherapy with ASH vs other psychotropic medications
Trial: 16946696
Drug: Lamotrigine adjunctive
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine adjunctive therapy with ASH
Trial: 6315123
Drug: Oral progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral progesterone 100 mg daily
Trial: 21174129
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy (BT) sleep intervention composed of stimulus control, modified sleep restriction (MSR), relaxation therapy (RT), and sleep hygiene counseling
Trial: 28735785
Drug: Separate length
RxNorm normalized name: Atractylis separate root
DrugBank: Atractylodes lancea root (DB14693)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate length determination and root canal preparation (Control)
Trial: 10023697
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) at 500 mg/body/day for 3 days
Trial: 22475362
Drug: Direct thrombin
RxNorm normalized name: Direct thrombin inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct thrombin inhibitors
Trial: 29699509
Drug: Short-term fasting
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term fasting (STF) during chemotherapy
Trial: 16801509
Drug: Adjusted low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjusted low-dose warfarin
Trial: 3300565
Drug: Etretinate therapy
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etretinate therapy